New insights into lipidic secondary metabolites in mycobacteria

Current Chemical Biology

Volumn 5, Issue 1, 2011, Pages 52-63

  Matsunaga, Isamu ^a   Sugita, Masahiko ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Lipids; Mycobacteria; Mycolic acid; Non ribosomal peptide synthetase; Polyketide synthase; Secondary metabolite

Indexed keywords

BCG VACCINE; CD1B ANTIGEN; CD1C ANTIGEN; CORD FACTOR; DIACYL TREHALOSE; FATTY ACID SYNTHASE; GLUCOSE 6 MONOMYCOLATE; GLYCOLIPID; GLYCOPEPTIDOLIPID; MANNOSE BETA 1 PHOSPHOMYCOKETIDE; MEMBRANE LIPID; MYCOBACTERIUM VACCINE; MYCOLIC ACID; PENTAACYL TREHALOSE; PHENOLIC GLYCOLIPID; PHTHIOCEROL DIMYCOCEROSATE; POLYKETIDE; POLYKETIDE SYNTHASE; T6 ANTIGEN; TREHALOSE; TREHALOSE 6 MYCOLATE; TRIACYL TREHALOSE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL CELL WALL; BACTERIAL IMMUNITY; CHEMICAL STRUCTURE; ENVIRONMENTAL STRESS; FATTY ACID SYNTHESIS; HUMAN; INFECTION CONTROL; LIPID METABOLISM; LIPOGENESIS; METABOLITE; MYCOBACTERIUM; MYCOBACTERIUM AVIUM; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TUBERCULOSIS;

CORYNEBACTERINEAE; FUNGI;

EID: 78951494170     PISSN: 18723136     EISSN: None     Source Type: Journal    
DOI: 10.2174/187231311793564360     Document Type: Article

References (68)

1. Daffe M. The global architecture of the mycobacterial cell envelope. In: Daffe M, Reyrat JM, Eds. The mycobacterial cell envelope. Washington, DC, ASM press. 2008; p. 3-11.
2. Takayama K, Wang L, David HL. Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis. Antimicrob Agents Chemother 1972; 2: 29-35.
3. Vilcheze C, Morbidoni HR, Weisbrod TR, et al. Inactivation of the inhA-encoded fatty acid synthase II (FASII) enoyl-acyl carrier protein reductase induces accumulation of the FASI end products and cell lysis of Mycobacterium smegmatis. J Bacteriol 2000; 82: 4059-67.
4. Barry CE, 3rd, Lee RE, Mdluli K, et al. Mycolic acids: structure, biosynthesis and physiological functions. Prog Lipid Res 1998; 37: 143-79.
5. Levy-Frebault VV, Portaels F. Proposed minimal standards for the genus Mycobacterium and for description of new slowly growing Mycobacterium species. Int J Syst Bacteriol 1992; 42: 315-23.
6. Matsunaga I, Naka T, Talekar RS, et al. Mycolyltransferase-mediated glycolipid exchange in Mycobacteria. J Biol Chem 2008; 283: 28835-41.
7. Onwueme KC, Vos CJ, Zurita J, Ferreras JA, Quadri LE. The dimycocerosate ester polyketide virulence factors of mycobacteria. Prog Lipid Res 2005; 44: 259-302.
8. Jackson M, Stadthagen G, Gicquel B. Long-chain multiple methyl-branched fatty acid-containing lipids of Mycobacterium tuberculosis: biosynthesis, transport, regulation and biological activities. Tuberculosis 2007; 87: 78-86.
9. Moody DB, Ulrichs T, Muhlecker W, et al. CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection. Nature 2000; 404: 884-8.
10. Matsunaga I, Bhatt A, Young DC, et al. Mycobacterium tuberculosis pks12 produces a novel polyketide presented by CD1c to T cells. J Exp Med 2004; 200: 1559-69.
11. de Jong A, Arce EC, Cheng TY, et al. CD1c presentation of synthetic glycolipid antigens with foreign alkyl branching motifs. Chem Biol 2007; 14: 1232-42.
12. Chatterjee D, Khoo KH. The surface glycopeptidolipids of mycobacteria: structures and biological properties. Cell Mol Life Sci 2001; 58: 2018-42.
13. Matsunaga I, Komori T, Ochi A, Mori N, Sugita M. Identification of antibody responses to the serotype-nonspecific molecular species of glycopeptidolipids in Mycobacterium avium infection. Biochem Biophys Res Commun 2008; 377: 165-9.
14. Portevin D, De Sousa-D'Auria C, Houssin C, et al. A polyketide synthase catalyzes the last condensation step of mycolic acid biosynthesis in mycobacteria and related organisms. Proc Natl Acad Sci 2004; 101: 314-9.
15. Biet F, Bay S, Thibault VC, et al. Lipopentapeptide induces a strong host humoral response and distinguishes Mycobacterium avium subsp. paratuberculosis from M. avium subsp. avium. Vaccine 2008; 26: 257-68.
16. Schweizer E, Hofmann J. Microbial type I fatty acid synthases (FAS): major players in a network of cellular FAS systems. Microbiol Mol Biol Rev 2004; 68: 501-17.
17. Takayama K, Wang C, Besra GS. Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis. Clin Microbiol Rev 2005; 18: 81-101.
18. Yadav G, Gokhale RS, Mohanty D. Computational approach for prediction of domain organization and substrate specificity of modular polyketide synthases. J Mol Biol 2003; 328: 335-63.
19. Watanabe K, Praseuth AP, Wang CC. A comprehensive and engaging overview of the type III family of polyketide synthases. Curr Opin Chem Biol 2007; 11: 279-86.
20. Lamichhane G, Zignol M, Blades NJ, et al. A postgenomic method for predicting essential genes at subsaturation levels of mutagenesis: application to Mycobacterium tuberculosis. Proc Natl Acad Sci 2003; 100: 7213-8.
21. Zimhony O, Vilcheze C, Jacobs WR, Jr. Characterization of Mycobacterium smegmatis expressing the Mycobacterium tuberculosis fatty acid synthase I (fas1) gene. J Bacteriol 2004; 186: 4051-5.
22. Gavalda S, Leger M, van der Rest B, et al. The Pks13/FadD32 crosstalk for the biosynthesis of mycolic acids in Mycobacterium tuberculosis. J Biol Chem 2009; 284: 19255-64.
23. Besra GS, Sievert T, Lee RE, Slayden RA, Brennan PJ, Takayama K. Identification of the apparent carrier in mycolic acid synthesis. Proc Natl Acad Sci 1994; 91: 12735-9.
24. Sathyamoorthy N, Takayama K. Purification and characterization of a novel mycolic acid exchange enzyme from Mycobacterium smegmatis. J Biol Chem 1987; 262: 13417-23.
25. Belisle JT, Vissa VD, Sievert T, Takayama K, Brennan PJ, Besra GS. Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science 1997; 276: 1420-2.
26. Trivedi OA, Arora P, Vats A, et al. Dissecting the mechanism and assembly of a complex virulence mycobacterial lipid. Mol Cell 2005; 17: 631-43.
27. Simeone R, Constant P, Malaga W, Guilhot C, Daffe M, Chalut C. Molecular dissection of the biosynthetic relationship between phthiocerol and phthiodiolone dimycocerosates and their critical role in the virulence and permeability of Mycobacterium tuberculosis. FEBS J 2007; 274: 1957-69.
28. Sirakova TD, Thirumala AK, Dubey VS, Sprecher H, Kolattukudy PE. The Mycobacterium tuberculosis pks2 gene encodes the synthase for the hepta-and octamethyl-branched fatty acids required for sulfolipid synthesis. J Biol Chem 2001; 276: 16833-9.
29. Dubey VS, Sirakova TD, Kolattukudy PE. Disruption of msl3 abolishes the synthesis of mycolipanoic and mycolipenic acids required for polyacyltrehalose synthesis in Mycobacterium tuberculosis H37Rv and causes cell aggregation. Mol Microbiol 2002; 45: 1451-9.
30. Dubey VS, Sirakova TD, Cynamon MH, Kolattukudy PE. Biochemical function of msl5 (pks8 plus pks17) in Mycobacterium tuberculosis H37Rv: biosynthesis of monomethyl branched unsaturated fatty acids. J Bacteriol 2003; 185: 4620-5.
31. Chopra T, Banerjee S, Gupta S, et al. Novel intermolecular iterative mechanism for biosynthesis of mycoketide catalyzed by a bimodular polyketide synthase. PLoS Biol 2008; 6: e163.
32. Schorey JS, Sweet L. The mycobacterial glycopeptidolipids: structure, function, and their role in pathogenesis. Glycobiology 2008; 18: 832-41.
33. Billman-Jacobe H, McConville MJ, Haites RE, Kovacevic S, Coppel RL. Identification of a peptide synthetase involved in the biosynthesis of glycopeptidolipids of Mycobacterium smegmatis. Mol Microbiol 1999; 33: 1244-53.
34. Etienne G, Villeneuve C, Billman-Jacobe H, Astarie-Dequeker C, Dupont MA, Daffe M. The impact of the absence of glycopeptidolipids on the ultrastructure, cell surface and cell wall properties, and phagocytosis of Mycobacterium smegmatis. Microbiology 2002; 148: 3089-100.
35. Kocincova D, Winter N, Euphrasie D, Daffe M, Reyrat JM, Etienne G. The cell surface-exposed glycopeptidolipids confer a selective advantage to the smooth variants of Mycobacterium smegmatis in vitro. FEMS Microbiol Lett 2009; 290: 39-44.
36. Berdy J. Bioactive microbial metabolites. J Antibiot 2005; 58: 1-26.
37. Hunter RL, Olsen MR, Jagannath C, Actor JK. Multiple roles of cord factor in the pathogenesis of primary, secondary, and cavitary tuberculosis, including a revised description of the pathology of secondary disease. Ann Clin Lab Sci 2006; 36: 371-86.
38. Ryll R, Kumazawa Y, Yano I. Immunological properties of trehalose dimycolate (cord factor) and other mycolic acid-containing glycolipids-a review. Microbiol Immunol 2001; 45: 801-11.
39. Geisel RE, Sakamoto K, Russell DG, Rhoades ER. In vivo activity of released cell wall lipids of Mycobacterium bovis bacillus Calmette-Guerin is due principally to trehalose mycolates. J Immunol 2005; 174: 5007-15.
40. Bowdish DM, Sakamoto K, Kim MJ, et al. MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis. PLoS Pathog 2009; 5: e1000474.
41. Ishikawa E, Ishikawa T, Morita YS, et al. Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle. J Exp Med 2009; 206: 2879-88.
42. Yano I, Tomiyasu I, Kitabatake S, Kaneda K. Granuloma forming activity of mycolic acid-containing glycolipids in nocardia and related taxa. Acta Leprol 1984; 2: 341-9.
43. Kaneda K, Sumi Y, Kurano F, Kato Y, Yano I. Granuloma formation and hemopoiesis induced by C36-48-mycolic acid-containing glycolipids from Nocardia rubra. Infect Immun 1986; 54: 869-75.
44. Ueda S, Fujiwara N, Naka T, et al. Structure-activity relationship of mycoloyl glycolipids derived from Rhodococcus sp. 4306. Microb Pathog 2001; 30: 91-9.
45. Natsuhara Y, Oka S, Kaneda K, Kato Y, Yano I. Parallel antitumor, granuloma-forming and tumor-necrosis-factor-priming activities of mycoloyl glycolipids from Nocardia rubra that differ in carbohydrate moiety: structure-activity relationships. Cancer Immunol Immunother 1990; 31: 99-106.
46. Matsunaga I, Oka S, Fujiwara N, Yano I. Relationship between induction of macrophage chemotactic factors and formation of granulomas caused by mycoloyl glycolipids from Rhodococcus ruber (Nocardia rubra). J Biochem 1996; 120: 663-70.
47. Cox JS, Chen B, McNeil M, Jacobs WR, Jr. Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice. Nature 1999; 402: 79-83.
48. Sirakova TD, Dubey VS, Cynamon MH, Kolattukudy PE. Attenuation of Mycobacterium tuberculosis by disruption of a mas-like gene or a chalcone synthase-like gene, which causes deficiency in dimycocerosyl phthiocerol synthesis. J Bacteriol 2003; 185: 2999-3008.
49. Reed MB, Domenech P, Manca C, et al. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 2004; 431: 84-7.
50. Pinto R, Saunders BM, Camacho LR, Britton WJ, Gicquel B, Triccas JA. Mycobacterium tuberculosis defective in phthiocerol dimycocerosate translocation provides greater protective immunity against tuberculosis than the existing bacille Calmette-Guerin vaccine. J Infect Dis 2004; 189: 105-12.
51. Mehra V, Brennan PJ, Rada E, Convit J, Bloom BR. Lymphocyte suppression in leprosy induced by unique M. leprae glycolipid. Nature 1984; 308: 194-6.
52. Rousseau C, Winter N, Pivert E, et al. Production of phthiocerol dimycocerosates protects Mycobacterium tuberculosis from the cidal activity of reactive nitrogen intermediates produced by macrophages and modulates the early immune response to infection. Cell Microbiol 2004; 6: 277-87.
53. Robinson N, Kolter T, Wolke M, Rybniker J, Hartmann P, Plum G. Mycobacterial phenolic glycolipid inhibits phagosome maturation and subverts the pro-inflammatory cytokine response. Traffic 2008; 9(11): 1936-47.
54. Okamoto Y, Fujita Y, Naka T, Hirai M, Tomiyasu I, Yano I. Mycobacterial sulfolipid shows a virulence by inhibiting cord factor induced granuloma formation and TNF-alpha release. Microb Pathog 2006; 40: 245-53.
55. Saavedra R, Segura E, Tenorio EP, Lopez-Marin LM. Mycobacterial trehalose-containing glycolipid with immunomodulatory activity on human CD4+ and CD8+ T-cells. Microbes Infect 2006; 8: 533-40.
56. Barrow WW, Davis TL, Wright EL, Labrousse V, Bachelet M, Rastogi N. Immunomodulatory spectrum of lipids associated with Mycobacterium avium serovar 8. Infect Immun 1995; 63: 126-33.
57. Hines ME, 2nd, Jaynes JM, Barker SA, Newton JC, Enright FM, Snider TG, 3rd. Isolation and partial characterization of glycolipid fractions from Mycobacterium avium serovar 2 (Mycobacterium paratuberculosis 18) that inhibit activated macrophages. Infect Immun 1993; 61: 1-7.
58. Moody DB, Reinhold BB, Guy MR, et al. Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science 1997; 278: 283-6.
59. Ulrichs T, Moody DB, Grant E, Kaufmann SH, Porcelli SA. T-cell responses to CD1-presented lipid antigens in humans with Mycobacterium tuberculosis infection. Infect Immun 2003; 71: 3076-87.
60. Rosat JP, Grant EP, Beckman EM, et al. CD1-restricted microbial lipid antigen-specific recognition found in the CD8+ alpha beta T cell pool. J Immunol 1999; 162: 366-71.
61. Ferreras JA, Stirrett KL, Lu X, et al. Mycobacterial phenolic glycolipid virulence factor biosynthesis: mechanism and smallmolecule inhibition of polyketide chain initiation. Chem Biol 2008; 15: 51-61.
62. Moody DB, Young DC, Cheng TY, et al. T cell activation by lipopeptide antigens. Science 2004; 303: 527-31.
63. Nitschke M, Costa SG, Contiero J. Rhamnolipid surfactants: an update on the general aspects of these remarkable biomolecules. Biotechnol Prog 2005; 21: 1593-600.
64. Ron EZ, Rosenberg E. Natural roles of biosurfactants. Environ Microbiol 2001; 3: 229-36.
65. Al-Tahhan RA, Sandrin TR, Bodour AA, Maier RM. Rhamnolipid induced removal of lipopolysaccharide from Pseudomonas aeruginosa: effect on cell surface properties and interaction with hydrophobic substrates. Appl Environ Microbiol 2000; 66: 3262-8.
66. Freeman R, Geier H, Weigel KM, Do J, Ford TE, Cangelosi GA. Roles for cell wall glycopeptidolipid in surface adherence and planktonic dispersal of Mycobacterium avium. Appl Environ Microbiol 2006; 72: 7554-8.
67. Williams MM, Yakrus MA, Arduino MJ, et al. Structural analysis of biofilm formation by rapidly and slowly growing nontuberculous mycobacteria. Appl Environ Microbiol 2009; 75: 2091-8.
68. Ojha AK, Baughn AD, Sambandan D, et al. Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug-tolerant bacteria. Mol Microbiol 2008; 69: 164-74.